Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Paraganglioma × Observation × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Endocrine 1 CNS 1

Conditions

Prostatic Neoplasms 7 Neoplasms 7 Colorectal Neoplasms 4 Breast Neoplasms 4 Stomach Neoplasms 3 Multiple Myeloma 3 Lymphoma, Mantle-Cell 3 Lung Neoplasms 3 Leukemia, Myeloid, Acute 3 Carcinoma, Non-Small-Cell Lung 3 Carcinoma, Hepatocellular 3 Venous Thromboembolism 2 Recurrence 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Papillomavirus Infections 2 Pancreatic Neoplasms 2 Neuroblastoma 2 Neoplasm Metastasis 2 Motor Activity 2 Melanoma 2 Lymphoma, Follicular 2 Lymphoma 2 Leukemia, Myelomonocytic, Acute 2 Leukemia, Monocytic, Acute 2 Leukemia, Megakaryoblastic, Acute 2 Leukemia, Erythroblastic, Acute 2 Congenital Abnormalities 2 Colorectal Neoplasms, Hereditary Nonpolyposis 2 Burkitt Lymphoma 2 Brain Neoplasms 2

Interventions

3-Iodobenzylguanidine 2 cixutumumab 1 cabozantinib 1 atezolizumab 1 Sunitinib 1 Salts 1 Radiosurgery 1 Phenoxybenzamine 1 Octreotide 1 Observation 1 Iodine-131 1 Everolimus 1 Doxazosin 1 Axitinib 1 Acetates 1 3-(8-amino-1-(2-phenylquinolin-7-yl)imidazo(1,5-a)pyrazin-3-yl)-1-methylcyclobutanol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05082311 2022-02-10

PheoCard

Sanjay Gandhi Postgraduate Institute of Medical Sciences

Cardiomyopathies, Paraganglioma, Pheochromocytoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡